Neurophet and RapidAI Partner to Expand Treatment Monitoring Access
The agreement expands Neurophet's reach into U.S. health systems and focuses on monitoring Alzheimer's and MS treatment.
The agreement expands Neurophet's reach into U.S. health systems and focuses on monitoring Alzheimer's and MS treatment.